IS2196B - Blanda útskiptra bensimídasóla - Google Patents

Blanda útskiptra bensimídasóla

Info

Publication number
IS2196B
IS2196B IS6347A IS6347A IS2196B IS 2196 B IS2196 B IS 2196B IS 6347 A IS6347 A IS 6347A IS 6347 A IS6347 A IS 6347A IS 2196 B IS2196 B IS 2196B
Authority
IS
Iceland
Prior art keywords
substituted benzimidazole
mix
mix substituted
benzimidazole
substituted
Prior art date
Application number
IS6347A
Other languages
English (en)
Other versions
IS6347A (is
Inventor
Brülls Mikael
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6347A publication Critical patent/IS6347A/is
Publication of IS2196B publication Critical patent/IS2196B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS6347A 1999-10-22 2002-04-17 Blanda útskiptra bensimídasóla IS2196B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles
PCT/SE2000/001992 WO2001028558A1 (en) 1999-10-22 2000-10-13 Formulation of substituted benzimidazoles

Publications (2)

Publication Number Publication Date
IS6347A IS6347A (is) 2002-04-17
IS2196B true IS2196B (is) 2007-01-15

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6347A IS2196B (is) 1999-10-22 2002-04-17 Blanda útskiptra bensimídasóla

Country Status (35)

Country Link
US (1) US6730685B1 (is)
EP (1) EP1274427B1 (is)
JP (1) JP2003512327A (is)
KR (1) KR100785603B1 (is)
CN (1) CN1213751C (is)
AR (1) AR029005A1 (is)
AT (1) ATE304851T1 (is)
AU (1) AU782866B2 (is)
BG (1) BG65580B1 (is)
BR (1) BR0014895A (is)
CA (1) CA2425199C (is)
CO (1) CO5261533A1 (is)
CY (1) CY1106055T1 (is)
CZ (1) CZ20021375A3 (is)
DE (1) DE60022789T2 (is)
DK (1) DK1274427T3 (is)
EE (1) EE05175B1 (is)
ES (1) ES2246903T3 (is)
HU (1) HUP0203121A3 (is)
IL (2) IL149107A0 (is)
IS (1) IS2196B (is)
MX (1) MXPA02003900A (is)
MY (1) MY131971A (is)
NO (1) NO329545B1 (is)
NZ (1) NZ518155A (is)
PL (1) PL199868B1 (is)
RU (1) RU2286782C2 (is)
SE (1) SE9903831D0 (is)
SI (1) SI1274427T1 (is)
SK (1) SK286266B6 (is)
TR (1) TR200201103T2 (is)
TW (1) TWI236372B (is)
UA (1) UA74347C2 (is)
WO (1) WO2001028558A1 (is)
ZA (1) ZA200202905B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7271182B2 (en) * 2000-08-04 2007-09-18 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and use thereof
WO2002015908A1 (fr) * 2000-08-18 2002-02-28 Takeda Chemical Industries, Ltd. Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US7507746B2 (en) * 2003-02-24 2009-03-24 Mitsubishi Pharma Corporation Enantiomer of tenatoprazole and the use thereof in therapy
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
AU2007248949B2 (en) * 2006-05-09 2010-04-08 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
CN107109464B (zh) 2014-11-13 2021-03-30 3M创新有限公司 用于检测样品中细菌atp的包含atp-二磷酸水解酶的试剂盒
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2025078989A1 (en) * 2023-10-11 2025-04-17 Reena Patel Stabilized pharmaceutical compositions
WO2025181379A1 (en) * 2024-03-01 2025-09-04 Etico Lifesciences Private Limited Liquid, storage stable, directly injectable, pantoprazole formulations, their uses and manufacturing

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
DK399389A (da) * 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
RU2126252C1 (ru) 1992-07-28 1999-02-20 Астра Актиеболаг Препарат для инъекций и набор для инъекций, содержащие омепразол и его аналоги
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
AU2117399A (en) * 1998-01-20 1999-08-02 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
TWI236372B (en) 2005-07-21
JP2003512327A (ja) 2003-04-02
WO2001028558A1 (en) 2001-04-26
CA2425199A1 (en) 2001-04-26
SE9903831D0 (sv) 1999-10-22
PL354926A1 (en) 2004-03-22
AU782866B2 (en) 2005-09-01
HUP0203121A3 (en) 2004-01-28
SI1274427T1 (sl) 2006-02-28
CO5261533A1 (es) 2003-03-31
ES2246903T3 (es) 2006-03-01
DK1274427T3 (da) 2005-12-27
SK286266B6 (sk) 2008-06-06
EP1274427A1 (en) 2003-01-15
KR100785603B1 (ko) 2007-12-14
HK1051142A1 (en) 2003-07-25
EE05175B1 (et) 2009-06-15
CZ20021375A3 (cs) 2002-09-11
CN1213751C (zh) 2005-08-10
EE200200204A (et) 2003-04-15
IL149107A0 (en) 2002-11-10
BG65580B1 (bg) 2009-01-30
SK5392002A3 (en) 2002-10-08
TR200201103T2 (tr) 2002-08-21
NO20021860D0 (no) 2002-04-19
CN1382048A (zh) 2002-11-27
ZA200202905B (en) 2003-07-14
MY131971A (en) 2007-09-28
CY1106055T1 (el) 2011-04-06
EP1274427B1 (en) 2005-09-21
NO20021860L (no) 2002-05-21
AR029005A1 (es) 2003-06-04
AU1182301A (en) 2001-04-30
CA2425199C (en) 2010-12-07
NZ518155A (en) 2004-07-30
US6730685B1 (en) 2004-05-04
KR20020059637A (ko) 2002-07-13
ATE304851T1 (de) 2005-10-15
BR0014895A (pt) 2002-06-18
MXPA02003900A (es) 2002-09-30
IS6347A (is) 2002-04-17
PL199868B1 (pl) 2008-11-28
IL149107A (en) 2008-04-13
RU2286782C2 (ru) 2006-11-10
UA74347C2 (uk) 2005-12-15
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
HUP0203121A2 (hu) 2003-01-28
BG106602A (en) 2002-12-29
NO329545B1 (no) 2010-11-08

Similar Documents

Publication Publication Date Title
DE60026169D1 (de) Selektive neurokinin-antagonisten
CY2011002I1 (el) N-πυρραζολικοι αγωνιστες του α2α υποδοχεα
NO20020765L (no) Kjemiske forbindelser
NO20021637D0 (no) Kjemiske forbindelser
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
IS2196B (is) Blanda útskiptra bensimídasóla
NO990431D0 (no) Golfk°llehode
NO990814L (no) Kjemiske forbindelser
DE60044218D1 (de) em
DE60019572D1 (de) Resorcinderivate
DE50012089D1 (de) Saugstrahlpumpe
IS6052A (is) Resorsinól efnasamsetning
NO20022927L (no) Substituerte pyrrazoler
IT250424Y1 (it) Betoniera per calcestruzzo preconfezionato
DK1200423T3 (da) Substituerede pehnyluraciler
FI19991888L (fi) Salpalaite
NO993313D0 (no) Kjemiske forbindelser
IT1313907B1 (it) Miscelatore
SE9900906D0 (sv) Blandare
NO992540D0 (no) L°ftetralle
ES1045015Y (es) Mezcladora.
NO992685D0 (no) Stillas-l°pekatt
SK2241U (sk) Spojovací prostriedok
ITBO990416A0 (it) Betoniera .